16h
WGAU Athens Radio on MSNRecall alert for SinuCleanse nasal wash system due to microbial contaminationAscent Consumer Products Inc. is voluntarily recalling its Sinucleanse Soft Tip Squeeze Bottle Nasal Wash System due to a ...
The U.S. Food & Drug Administration (FDA) has announced the voluntary recall of a sinus nasal wash bottle system following a confirmed test result of microbial contamination.
18h
The Healthy on MSNA Cold, Sinus and Allergy Product Sold at Walmart and Other Retailers Has Been Recalled NationwideWith respiratory illnesses still circulating, this is a reminder why it's essential to follow best practice with this type of ...
Nasal spray options include steroids (e.g. Flonase, Nasacort), which are best for allergies and long-term inflammation but ...
An environmentalist has issued a warning to anyone visiting certain UK beaches after spotting thousands of identical items ...
The company's nasal spray is a popular one for those who need a little extra help when it comes to their sinuses, and the over the counter medication is pretty easy to use, making it a first choice ...
The US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical company Johnson & Johnson created the spray from esketamine, a more ...
Figuring out how to stop post-nasal drip quickly can help mitigate the other uncomfortable symptoms of the phenomenon, like sore throat or stomach upset. While post-nasal drip is typically a mild ...
A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with severe depression, the FDA says. Here's what that means.
Resyca® specialises in the development and manufacturing of compact, user-friendly soft mist inhalation and soft nasal spray devices, incorporating the proprietary Medspray micro-nozzle technology.
Resyca ® specialises in the development and manufacturing of compact, user-friendly soft mist inhalation and soft nasal spray devices, incorporating the proprietary Medspray micro-nozzle technology.
The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results